Sentinel Node Biopsy should be supplemented by axillary sampling in patients with small breast cancers

International Seminars in Surgical Oncology

Volumn 2, Issue , 2005, Pages

  Adwani, Asha ^a   Ebbs, Steve R ^a   Burton, Sarah ^a   Lowe, Susan ^a  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Axillary sampling; Early breast cancer; Guided axillary sampling; Sentinel node biopsy

Indexed keywords

DYE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; EARLY CANCER; HUMAN; IMAGING SYSTEM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; PROGNOSIS; QUANTITATIVE ANALYSIS; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

EID: 28844474405     PISSN: 14777800     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-2-27     Document Type: Article

References (26)

1. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 351:1451-1467.
2. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;352:930-942.
3. Ivens D, Hoe AL, Podd TJ, et al.: Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-138.
4. Kissin MW, Querci della Rovere G, Easton D, Westbury G: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986;73:580-584.
5. Moffat FL, Jr., Senofsky GM, Davis K, et al.: Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992;51:8-13.
6. Cady B, Stone MD, Schuler JG, et al.: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-308.
7. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187.
8. Hsueh EC, Hansen N, Giuliano AE: Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA Cancer J Clin 2000;50:279-291.
9. Veronesi U, Zurrida S, Galimberti V: Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies. Eur J Surg Oncol 1998;24:93-95.
10. Ahlgren J, Holmberg L, Bergh J, Liljegren G: Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol 2002;28:97-102.
11. Barthelmes L, Al-Awa A, Murali-Krishnan VP, Crawford DJ: The role of lymph node sampling and radiotherapy in the management of the axilla in early breast cancer. Breast 2002;11:236-240.
12. Chetty U, Jack W, Prescott RJ, et al.: Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg 2000;87:163-169.
13. Forrest AP, Everington D, McDonald CC, et al.: The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 1995;82:1504-1508.
14. Hoar FJ, Stonelake PS: A prospective study of the value of axillary node sampling in addition to sentinel lymph node biopsy in patients with breast cancer. Eur J Surg Oncol 2003;29:526-531.
15. Macmillan RD, Barbera D, Hadjiminas DJ, et al.: Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer 2001;37:1076-1080.
16. Fentiman IS, Mansel RE: The axilla: not a no-go zone. Lancet 1991;337:221-223.
17. Barth A, Craig PH, Silverstein MJ: Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997;79:1918-1922.
18. Jackson JS, Olivotto IA, Wai MDE, et al.: A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma. Cancer 2000;88:1852-1862.
19. Pain JA, Ebbs SR, Hern RP, et al.: Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol 1992;18:44-48.
20. Di Loreto C, Puglisi F, Rimondi G, et al.: Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. Eur J Cancer 1996;32A:1693-1700.
21. Connor CS, Tawfik OW, Joyce AJ, et al.: A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. Am J Surg 2002;184:322-324.
22. McIntosh SA, Panchalingam L, Payne S, et al.: Freehand core biopsy in breast cancer: an accurate predictor of tumour grade following neoadjuvant chemotherapy? Breast 2002;11:496-500.
23. Denley H, Pinder SE, Elston CW, et al.: Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol 2001;54:20-24.
24. Harris K, Morafa I, Thomas V, Mokbel K: Core biopsy is accurate in determining the hormone receptor status of early breast cancer. Am J Surg 2004;187:568; author reply 668.
25. Douglas-Jones AG, Collett N, Morgan JM, Jasani B: Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol 2001;54:951-955.
26. Shannon J, Douglas-Jones AG, Dallimore NS: Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol 2001;54:762-765.